Vendor Intelligence Report: Shanghai OuDaXin New Material Technology Center

Published 12 Jun 2026. 22-page investigative report on who is behind Shanghai OuDaXin New Material Technology Center: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Shanghai OuDaXin shows a 73% overall Finnrick pass rate across 45 tests, with tirzepatide the least weak tested option and tesamorelin the clear avoid-without-fresh-verification product. The full…